ENDRA LIFE SCIENCES INC. Amortization of Debt Discount (Premium)
ENDRA LIFE SCIENCES INC. (NDRA) reported Amortization of Debt Discount (Premium) of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2022-03-30
- ENDRA LIFE SCIENCES INC. amortization of debt discount (premium) for the quarter ending 2021-12-31 was $0.00.
- ENDRA LIFE SCIENCES INC. amortization of debt discount (premium) for the quarter ending 2021-09-30 was $0.00.
- ENDRA LIFE SCIENCES INC. amortization of debt discount (premium) for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- ENDRA LIFE SCIENCES INC. amortization of debt discount (premium) for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- ENDRA LIFE SCIENCES INC. amortization of debt discount (premium) for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- ENDRA LIFE SCIENCES INC. amortization of debt discount (premium) for fiscal 2020 was $232.43K, a 90.13% decline from fiscal 2019.
- ENDRA LIFE SCIENCES INC. amortization of debt discount (premium) for fiscal 2019 was $2.36M, a 223.00% increase from fiscal 2018.
- ENDRA LIFE SCIENCES INC. amortization of debt discount (premium) for fiscal 2018 was $729.24K, a 2.50% increase from fiscal 2017.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $0.00 10-K · filed 2022-03-30 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 4 quarters · filed 2022-03-30 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $0.00 derived: sum of 4 quarters · filed 2022-03-30 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $3.86K derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $3.86K derived: sum of 3 quarters · filed 2022-03-30 | $232.43K 10-K · filed 2022-03-30 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $3.86K derived: sum of 2 quarters · filed 2021-11-15 | $232.43K 10-Q · filed 2021-11-15 | $1.86M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $3.86K 10-Q · filed 2021-08-12 | $232.43K 10-Q · filed 2021-08-12 | $1.86M derived: sum of 3 quarters · filed 2021-08-12 | $2.59M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $228.57K 10-Q · filed 2021-05-17 | $1.86M derived: sum of 2 quarters · filed 2021-05-17 | $2.58M derived: sum of 3 quarters · filed 2021-05-17 | $2.58M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $2.36M derived: sum of 2 quarters · filed 2021-03-25 | $2.36M derived: sum of 3 quarters · filed 2021-03-25 | $2.36M 10-K · filed 2021-03-25 |
| 2019-09-30 | $728.42K 10-Q · filed 2020-11-16 | $728.42K derived: sum of 2 quarters · filed 2020-11-16 | $728.42K 10-Q · filed 2020-11-16 | $1.07M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 | $345.81K derived: sum of 3 quarters · filed 2020-08-14 | $723.42K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-14 | $345.81K derived: sum of 2 quarters · filed 2020-05-14 | $723.42K derived: sum of 3 quarters · filed 2020-05-14 | $729.24K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $345.81K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $723.42K derived: sum of 2 quarters · filed 2020-03-26 | $729.24K derived: sum of 3 quarters · filed 2020-03-26 | $729.24K 10-K · filed 2020-03-26 |
| 2018-09-30 | $377.61K 10-Q · filed 2019-11-13 | $383.43K derived: sum of 2 quarters · filed 2019-11-13 | $383.43K 10-Q · filed 2019-11-13 | $1.09M derived: sum of 4 quarters · filed 2019-11-13 |
| 2018-06-30 | $5.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $5.82K 10-Q · filed 2018-08-13 | $717.29K derived: sum of 3 quarters · filed 2019-03-11 | $717.29K derived: sum of 4 quarters · filed 2019-03-11 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-15 | $711.47K derived: sum of 2 quarters · filed 2019-03-11 | $711.47K derived: sum of 3 quarters · filed 2019-03-11 | $711.47K derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-12-31 | $711.47K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | $711.47K derived: sum of 2 quarters · filed 2019-03-11 | $711.47K derived: sum of 3 quarters · filed 2019-03-11 | $711.47K 10-K · filed 2019-03-11 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $0.00 derived: sum of 2 quarters · filed 2018-11-05 | $0.00 10-Q · filed 2018-11-05 | |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-07 | $0.00 10-Q · filed 2018-08-13 | ||
| 2017-03-31 | $351.73K 10-Q · filed 2018-05-15 | |||
| 2016-12-31 | $899.98K 10-K · filed 2018-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |